The IMID Forum cover image

EULAR 2024 Review Podcast

The IMID Forum

CHAPTER

Analysis of Sustained Remission Study and Safety of JAK Inhibitors

The chapter covers a remission study in patients with active disease, showing a high flare rate after treatment cessation, and explores predictors of inactive disease. It also evaluates the safety profile of JAK inhibitors versus TNF and IL-17 inhibitors, revealing no elevated risks in cardiovascular disease, VTEs, or cancer at multiple time points.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner